The Effect of Statins on Clinical Outcome Among Hospitalized Patients With COVID-19: A Multi-Centric Cohort Study
The coronavirus disease-2019 (COVID-19) is caused by SARS-CoV-2, leading to acute respiratory distress syndrome (ARDS), thrombotic complications, and myocardial injury. Statins, prescribed for lipid reduction, have anti-inflammatory, anti-thrombotic, and immunomodulatory properties and are associate...
Shranjeno v:
| Principais autores: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2022-07-01
|
| Serija: | Frontiers in Pharmacology |
| Teme: | |
| Online dostop: | https://www.frontiersin.org/articles/10.3389/fphar.2022.742273/full |
| Oznake: |
Brez oznak, prvi označite!
|